Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice
Authors
Keywords
-
Journal
CLINICAL TRANSPLANTATION
Volume -, Issue -, Pages e13512
Publisher
Wiley
Online
2019-03-01
DOI
10.1111/ctr.13512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety
- (2019) Brianne M. Ritchie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of a New Paradigm for Cytomegalovirus Disease Prevention in Mayo Clinic’s First Face Transplant
- (2019) Raymund R. Razonable et al. MAYO CLINIC PROCEEDINGS
- A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor
- (2018) Flavio Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by in vitro Exposure to Letermovir and Ganciclovir
- (2018) Sunwen Chou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Control of Cytomegalovirus Viremia after Allogeneic Stem Cell Transplantation: A Review on CMV-Specific T Cell Reconstitution
- (2018) Pim van der Heiden et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients
- (2018) Bradley J Gardiner et al. CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- New Developments in the Management of Cytomegalovirus Infection After Transplantation
- (2018) Atibordee Meesing et al. DRUGS
- Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results
- (2018) Klaudia Naegele et al. JOURNAL OF CLINICAL VIROLOGY
- T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients
- (2018) Smaranda Gliga et al. JOURNAL OF CLINICAL VIROLOGY
- Assigning Cytomegalovirus Status in Children Awaiting Organ Transplant: Viral Shedding, CMV-Specific T Cells, and CD27−CD28−CD4+ T Cells
- (2018) Catherine E Burton et al. JOURNAL OF INFECTIOUS DISEASES
- Assignment of cytomegalovirus infection status in infants awaiting solid organ transplant: Viral detection methods as adjuncts to serology
- (2018) Catherine E. Burton et al. PEDIATRIC TRANSPLANTATION
- Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study
- (2018) Dimitrios Chanouzas et al. PLoS One
- Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
- (2018) Bernhard Banas et al. TRANSPLANT INTERNATIONAL
- Deep Profiling of the CD8+ T cell Compartment identifies Activated cell subsets and Multifunctional Responses Associated with Control of Cytomegalovirus Viremia
- (2018) Victor H. Ferreira et al. TRANSPLANTATION
- The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
- (2018) Camille N. Kotton et al. TRANSPLANTATION
- Pharmacologic and Immunologic Management of Cytomegalovirus Infection after Solid Organ and Hematopoietic Stem Cell Transplantation
- (2018) Atibordee Meesing et al. Expert Review of Clinical Pharmacology
- Absolute Lymphocyte Count Thresholds: A Simple Readily Available Tool to Predict the Risk of Cytomegalovirus Infection after Transplantation
- (2018) Atibordee Meesing et al. Open Forum Infectious Diseases
- Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection
- (2018) Lauren Cherrier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
- (2018) Genovefa A Papanicolaou et al. CLINICAL INFECTIOUS DISEASES
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
- (2018) Francisco M. Marty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Differentiated Levels of Ganciclovir Resistance Conferred by Mutations at Codons 591 to 603 of the Cytomegalovirus UL97 Kinase Gene
- (2017) Sunwen Chou et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
- (2017) Ifigeneia Tzannou et al. JOURNAL OF CLINICAL ONCOLOGY
- Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients
- (2017) Yupin Tong et al. JOURNAL OF INFECTIOUS DISEASES
- Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
- (2017) M Neuenhahn et al. LEUKEMIA
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease
- (2017) M Veronica Dioverti et al. Open Forum Infectious Diseases
- Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples
- (2016) Jutta K. Preiksaitis et al. CLINICAL INFECTIOUS DISEASES
- Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
- (2016) Per Ljungman et al. CLINICAL INFECTIOUS DISEASES
- Treatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?
- (2016) M. Veronica Dioverti et al. CLINICAL TRANSPLANTATION
- Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis
- (2016) E. Beam et al. CLINICAL TRANSPLANTATION
- Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection
- (2016) Janine Mihm et al. JOURNAL OF CLINICAL VIROLOGY
- A risk-stratified approach to cytomegalovirus prevention in pediatric solid organ transplant recipients
- (2016) Sneha Suresh et al. PEDIATRIC TRANSPLANTATION
- Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation
- (2016) M. Alhefzi et al. Transplant Infectious Disease
- Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients
- (2016) Julio Pascual et al. Transplant Infectious Disease
- Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study
- (2016) P.G. Young et al. Transplant Infectious Disease
- Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients
- (2016) C.E. Fisher et al. Transplant Infectious Disease
- Resistant cytomegalovirus in intestinal and multivisceral transplant recipients
- (2016) J.G. Timpone et al. Transplant Infectious Disease
- Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation
- (2016) Shunji Nagai et al. TRANSPLANTATION
- Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
- (2016) Robin K. Avery et al. TRANSPLANTATION
- Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation
- (2016) T. Ambrose et al. TRANSPLANTATION PROCEEDINGS
- Adoptive T Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cytomegalovirus Disease in a Renal Transplant Recipient
- (2015) N. Macesic et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus-based immunosuppressive regimens in lung transplant recipients: Impact on CMV infection
- (2015) Massimo Rittà et al. ANTIVIRAL RESEARCH
- Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis
- (2015) D.R. Stevens et al. Transplant Infectious Disease
- It's not too late: a proposal to standardize the terminology of “late-onset” cytomegalovirus infection and disease in solid organ transplant recipients
- (2015) R.R. Razonable et al. Transplant Infectious Disease
- The Role of Secondary Cytomegalovirus Prophylaxis for Kidney and Liver Transplant Recipients
- (2015) Timothy Sullivan et al. TRANSPLANTATION
- Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients
- (2014) Marc Lúcia et al. CLINICAL INFECTIOUS DISEASES
- Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation
- (2013) Scott M. Palmer ANNALS OF INTERNAL MEDICINE
- Virologic Suppression Measured by a Cytomegalovirus (CMV) DNA Test Calibrated to the World Health Organization International Standard Is Predictive of CMV Disease Resolution in Transplant Recipients
- (2013) Raymund R. Razonable et al. CLINICAL INFECTIOUS DISEASES
- Detection of Cytomegalovirus DNA in Plasma as an Adjunct Diagnostic for Gastrointestinal Tract Disease in Kidney and Liver Transplant Recipients
- (2013) C. M. Durand et al. CLINICAL INFECTIOUS DISEASES
- Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation
- (2013) R. R. Razonable et al. CLINICAL MICROBIOLOGY REVIEWS
- Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure inde novorenal transplant patients
- (2013) Björn Nashan CLINICAL TRANSPLANTATION
- Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing
- (2013) Malaya K. Sahoo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
- (2013) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
- (2012) S. F. Atabani et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Infections Following Facial Composite Tissue Allotransplantation-Single Center Experience and Review of the Literature
- (2012) B. M. Knoll et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
- (2012) O. Manuel et al. CLINICAL INFECTIOUS DISEASES
- An International Multicenter Performance Analysis of Cytomegalovirus Load Tests
- (2012) H. H. Hirsch et al. CLINICAL INFECTIOUS DISEASES
- Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis
- (2012) Guy Boivin et al. JOURNAL OF CLINICAL VIROLOGY
- Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis
- (2012) A.P. Wiita et al. Transplant Infectious Disease
- Everolimus-Treated Renal Transplant Recipients Have a More Robust CMV-Specific CD8+ T-Cell Response Compared With Cyclosporine- or Mycophenolate-Treated Patients
- (2012) Simone H.C. Havenith et al. TRANSPLANTATION
- First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246
- (2011) D. R. Kaul et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials
- (2011) D. C. Brennan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Late Cytomegalovirus Transmission and Impact of T-Depletion in Clinical Islet Transplantation
- (2011) B. L. Gala-Lopez et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cyclopropavir Susceptibility of Cytomegalovirus DNA Polymerase Mutants Selected after Antiviral Drug Exposure
- (2011) Sunwen Chou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation
- (2011) Dana G. Wolf et al. ANTIVIRAL RESEARCH
- The biology of cytomegalovirus drug resistance
- (2011) Morgan Hakki et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: A single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial
- (2011) C. Ashley Finlen Copeland et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
- (2011) Paul D Griffiths et al. LANCET
- Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
- (2011) Raymund R. Razonable MAYO CLINIC PROCEEDINGS
- The risk of cytomegalovirus recurrence after kidney transplantation
- (2011) Ilkka Helanterä et al. TRANSPLANT INTERNATIONAL
- Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients
- (2011) Corinna La Rosa et al. TRANSPLANT INTERNATIONAL
- Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients
- (2011) Hans-Arne Myhre et al. TRANSPLANTATION
- Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia
- (2011) Luiz F. Lisboa et al. TRANSPLANTATION
- Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial
- (2011) Oliver Witzke et al. TRANSPLANTATION
- The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
- (2010) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004
- (2010) Sheri Lewis Bate et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of Valganciclovir 900 mg versus 450 mg for Cytomegalovirus Prophylaxis in Transplantation: Direct and Indirect Treatment Comparison Meta-analysis
- (2010) A. C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Antiviral Drug Resistance of Human Cytomegalovirus
- (2010) N. S. Lurain et al. CLINICAL MICROBIOLOGY REVIEWS
- New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation
- (2010) Albert J. Eid et al. DRUGS
- Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
- (2010) Michael J. Cannon et al. REVIEWS IN MEDICAL VIROLOGY
- Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients
- (2010) R.K. Avery et al. Transplant Infectious Disease
- Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance
- (2010) Martha T. van der Beek et al. TRANSPLANTATION
- Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study
- (2010) Atul Humar et al. TRANSPLANTATION
- Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes
- (2010) Robin K. Avery et al. TRANSPLANTATION
- Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
- (2010) Noémie Boillat Blanco et al. TRANSPLANTATION
- The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response
- (2010) Luiz F. Lisboa et al. TRANSPLANTATION
- Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients
- (2009) A. J. Eid et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
- (2009) D. Kumar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients
- (2009) A. Åsberg et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The impact of invasive fungal diseases on survival after lung transplantation
- (2009) Supha K. Arthurs et al. CLINICAL TRANSPLANTATION
- Direct and indirect effects of cytomegalovirus: can we prevent them?
- (2009) Raymund Razonable ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Immune-based therapies for cytomegalovirus infection
- (2009) Raymund R Razonable Immunotherapy
- An Assessment of Donor‐to‐Recipient Transmission Patterns of Human Cytomegalovirus by Analysis of Viral Genomic Variants
- (2009) Oriol Manuel et al. JOURNAL OF INFECTIOUS DISEASES
- A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection
- (2009) Albert J Eid et al. TRANSPLANT INTERNATIONAL
- Improvement in Long-Term Renal Graft Survival due to CMV Prophylaxis with Oral Ganciclovir: Results of a Randomized Clinical Trial
- (2008) V. Kliem et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation
- (2008) S. K. Arthurs et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started